Agree, that is what is attracting me to this company. They are publishing quarterly results and doing con calls which is rare for a company on NSE Emerge. In fact I have noticed that many companies on main board don’t do concalls.

Disclaimer: Not invested but tracking closely

Good one @suru27 bhai.

I do not agree with this specific Risk though.

Increase in insurance penetration: A higher-than-expected increase in insurance penetration would affect the margins of the hospital as a whole.

Increase in insurance penetration would be beneficial for all types of organized hospital chains. The Chairman has insisted on the virtures of a cheap medical insurance on several ocassions. Even the latest Annual Report talks about it.

Since the merger ratio was announced at 10 of GGL for 13 of GSPL, GSPL should trade at approximately 350 if we consider GGL CMP of 450, so there is a slight discount on that front (GSPL CMP 325). So, now GSPL will basically mimic GGL with slight differences. Meanwhile, GGL is facing issues like all gas distribution companies with reduction in APM allocation and price of new well gas (priced at 12% of Indian crude basket) being at 20% premium to APM so this needs to be passed onto customers which can hurt volumes. All gas distribution companies like IGL, Adani Total Gas and Gujarat Gas have corrected quite a bit in past few weeks. Also, shareholders of GGL are exposed to GSPC indirectly till the time merger concludes so that is also a risk and outcome of appeal by GSPL against the tariff reduction by PNGRB will be significant.

FY25-20-22% growth with some improvement in margins.
FY26- expected 2300 Cr revenue, 1600 Cr from existing business and 700 Cr from smart meters.

EV chargers business issue will be solved by Dec’24 end, expecting significant revenue from FY27 with exisiting capacity of 100 Chargers/ Month at an Avg cost of 8-10 lacs. Capacity may ramp up in FY26

Is there any update on the company’s transfer to the mainboard exchange?